Therapeutic and management Issues related to skin cancer are dealt with on a daily basis by Dermatologists and lack of a comprehensive therapeutic and management issues can lead to increased morbidity and mortality. This course will be designed to related present key factors that impact on patient care and how to apply current therapies and management approaches. Spirited Questions and Answers with active audience participation will be encouraged. This symposium will work toward delivering practical therapeutic and management solutions to these issues that can be immediately incorporated into the attendee’s patient care setting.
This activity has been approved by the American Board of Dermatology (ABD) for up to 30 MOC Component 2 Self-Assessment points. For more information about MOC, please visit the ABD website at www.abderm.org.
Dr. Rigel / Introduction: Why the issue is Important
Dr. Ceilley / Field vs Lesional Therapies for AKs – When to use Which?
Dr. Farberg / Using Hedgehog Inhibitors in practice. Current and future Challenges
Dr. Wang / Oral supplements in photoprotection
Dr. Lim / Dilemmas associated with Oxybenzone in Sunscreens
Dr. Fromowitz / Is superficial radiation no longer a forgotten approach for NMSC
Dr. Lebwohl / Do Biologics cause skin cancer?
Dr. Ceilley, Dr. Wang, Dr. Lim, Dr. Fromowitz, Dr. Lebwohl, and Dr. Farberg / Q&A
Dr. Leachman / Assessing Melanoma Risk with Genetic Testing: Who and When?
Dr. Rigel / The Dilemma of the Dysplastic Nevus – How are your colleagues managing these lesions?
Dr. Marghoob / Key Factors in successful integration of Dermoscopy in your clinical setting
Dr. High / New approaches in Pigmented lesion diagnosis – Pathology genetics and devices
Dr. Ferris / Integrating Genetics into assessing skin cancer prognosis
Dr. Desai / Skin Cancer Issues in Skin of Color
Dr. Marghoob, Dr. Ferris, Dr. High, Dr. Desai, Dr. Rigel, and Dr. Leachman / Q&A